title: [Comments on American Society of Clinical Oncology/College of American Pathologists for HER2 testing in breast cancer].
authors.affiliation: Department of Pathology, Unversity of Texas M.D. Anderson Cancer Center, Houston, Tx 77030, USA. yungong@mdanderson.org
authors.forename: Yun
authors.initials: Y
authors.lastname: Gong
authors.forename: Chun-hua
authors.initials: CH
authors.lastname: Xiao
authors.forename: Li
authors.initials: L
authors.lastname: Fu
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002863:Chromogenic Compounds; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D017410:Practice Guidelines as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D012955:Societies, Medical; D014481:United States
chemical_list: D002863:Chromogenic Compounds; D018719:Erb-b2 Receptor Tyrosine Kinases